Riskpilot← Back to searchSign inGet full accessDr. Arbab AB
ABActiveOrg 5569785669Krögarvägen 135General medical practice activities · NACE 8621Est. 20142 employees
Revenue 2025
SEK 3M
+11% vs 2024
EBITDA margin
51.5%
+29% vs 2024
Equity ratio
94.6%
Financial strength
Net profit 2025
SEK 1,2M
+37% vs 2024
| Revenue | SEK 3M | +11% |
| EBITDA | SEK 1,5M | +29% |
| Net profit | SEK 1,2M | +37% |
| Total assets | SEK 4,9M | +16% |
| Equity | SEK 4,6M | +19% |
| Employees | 2 | — |
Legal name
Dr. Arbab AB
Org number
5569785669
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
1 augusti 2014
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Konsultverksamhet inom primärvården. Läkarbemanning av vårdcentraler, hemsjukvård och särskildboende.
Address
Krögarvägen 135
Email
nangialai9@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 880 | 2 486 | 2 330 | 2 669 | 2 951 |
| Staff expenses | — | −1 064 | −1 129 | −1 210 | −1 211 |
| EBITDA | 1 526 | 1 263 | 937 | 1 177 | 1 519 |
| Depreciation & amort. | −104 | −782 | −197 | −104 | −64 |
| EBIT | 1 422 | 481 | 740 | 1 073 | 1 455 |
| Net financials | — | −10 | 4 | 5 | 15 |
| Profit before tax | 1 422 | 472 | 744 | 1 078 | 1 470 |
| Tax | −293 | −97 | −153 | −222 | −300 |
| Net profit | 1 129 | 374 | 591 | 856 | 1 169 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 4 044 | 3 642 | 3 601 | 4 203 | 4 861 |
| Equity | 3 229 | 3 213 | 3 414 | 3 880 | 4 599 |
| Long-term debt | 599 | 453 | 242 | 242 | 68 |
| Short-term debt | 217 | −23 | −55 | 81 | 194 |
| Total debt | 816 | 429 | 187 | 323 | 262 |
EBITDA margin
51.5%
This company
15.8%
Market median
+226% vs market
20212025
Equity ratio
94.6%
This company
38.2%
Market median
+148% vs market
20212025
Return on equity
25.4%
This company
18.4%
Market median
+38% vs market
20212025
Net profit margin
39.6%
This company
8.1%
Market median
+389% vs market
20212025
Asset turnover
0.61×
This company
1.12×
Market median
-46% vs market
20212025
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Dr. Arbab AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Uzma Khalil | Deputy Board Member | 0 companies |
| Nangialai Khalil | Board of Directors | 0 companies |